Adherence to NCCN Survivorship Care Guidelines in Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,440
- 试验地点
- 2
- 主要终点
- Percentage of eligible CRC and NSCLC survivors with medical record documentation of compliance with NCCN guidelines
研究概览
简要总结
This clinical trial studies adherence to survivorship care guidelines in health care providers for non-small cell lung cancer or colorectal cancer survivor care. The completion of an educational intervention by health care providers may increase compliance and adherence to National Comprehensive Cancer Network guidelines for survivorship care.
详细描述
PRIMARY OBJECTIVES:
I. To evaluate adherence of oncology health care providers to National Comprehensive Cancer Network (NCCN) guidelines for cancer survivorship care in colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) cancers.
SECONDARY OBJECTIVES:
I. To develop and assess a targeted educational initiative to improve compliance with NCCN CRC and NSCLC survivorship guidelines for oncology health care providers in academic and community practice.
II. To evaluate the impact of this educational initiative on documented adherence and compliance with NCCN guidelines for NSCLC and CRC survivorship care by oncology health care providers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HEALTH CARE PROVIDER INCLUSION CRITERIA:
- •Any health care provider (physician, advanced practice clinician) at a study site (Fox Chase Cancer Center [FCCC] and Fox Chase Cancer Center Partners [FCCCP]) who provides care for NSCLC and/or CRC survivors
- •CHART AUDIT INCLUSION CRITERIA (BASELINE):
- •Cancer Registry cases include stage I-III colon cancer (adenocarcinoma histology), stage I-III rectal cancer (adenocarcinoma histology), stage I-III non-small cell lung cancer (squamous or adenocarcinoma histology)
- •Patients must have completed all therapy for curative intent at least six months prior to chart audit
- •Undergoing routine oncology care and surveillance at the chosen site (defined as receiving follow-up care with FCCC or FCCCP site health care providers and have an active medical chart)
- •No evidence of metastatic disease
- •Patients must have been seen for a visit for cancer surveillance between 2009 and 2013
- •Health care providers at the participating site must be willing and able to participate in the educational initiative
- •CHART AUDIT INCLUSION CRITERIA (POST-INTERVENTION)
- •Charts eligible for audit after completion of the educational initiative will be for those CRC and NSCLC survivors presenting for follow-up after the initiative has been completed by site health care providers
排除标准
- •CHART AUDIT EXCLUSION CRITERIA:
- •Cancer Registry cases for diseases other than colon or rectal adenocarcinoma and non-small cell lung cancer (squamous or adenocarcinoma histology)
- •Patients currently receiving active therapy for any cancer, including CRC or NSCLC
- •Patients who do not undergo routine oncologic care at the chosen Partners site or Fox Chase Cancer Center
- •Stage IV cancer or evidence of metastatic disease at any time point
- •Patients who have not undergone a visit for cancer surveillance since 2009
- •Fox Chase Cancer Partners sites who do not agree to chart audit procedures or providers are unable or unwilling to participate in the educational initiative
结局指标
主要结局
Percentage of eligible CRC and NSCLC survivors with medical record documentation of compliance with NCCN guidelines
时间窗: Up to 6 months
A test of the binomial proportion will have 99% power with 1% type I error to make this distinction.
次要结局
- Change in percentage of eligible survivors with documentation of compliance with NCCN survivorship guidelines after conducting the targeted educational initiative at participating sites(Baseline and up to 6 months)